Glycosylation pathways are determined at many levels from the genome to the proteome and by the environment of the cells in the culture. Glycans have an influence on the safety and efficacy of many biological drugs, so it is necessary to understand the outcome that is relevant to the mode of action of the product. What are some of the best ways to manipulate and monitor the glycosylation pathways?Session: Variations in Glycosylation of Biopharmaceuticals: Approaches to Controlling the Pathways and Analyzing the Glycans
Speaker: Pauline M. Rudd, Ph.D., NIBRT Research Professor, Dublin-Oxford Glycobiology Laboratory, NIBRT, Ireland
Want to learn more about monitoring the interventions of these pathways? Attend the full session at IBC's Product and Process Variants & Impurities event: Process Monitoring and Control Strategies for Purifying Variants and Impurities. Download our agenda to learn more.
As a reader of this blog, you’ll receive 15% off the standard rate when using code XB13194BLOG to register. If you have questions about the event, contact Kate Devery (Kdevery@iirusa.com), or visit our webpage. We look forward to seeing you October 21-23 in Washington, D.C!
|
Share this article with your social network, just click below to share now!
|
|
|
